Sanara Surgical Revenue Growth
Sanara Surgical delivered net revenue of $23.4 million, representing 26% growth year-over-year, driven by a 28% increase in soft tissue repair product sales.
Strong Performance in Product Sales
Sales of CellerateRX Surgical and BIASURGE products fueled performance, and bone fusion products also saw an 18% increase year-over-year.
Enhanced Gross Margins
Gross profit increased by $5 million to $21.6 million, with a gross margin increase of approximately 240 basis points to 92% of net revenue.
Adjusted EBITDA Improvement
Sanara Surgical Segment adjusted EBITDA increased by $1.5 million year-over-year to $2.7 million.
Expansion of Distributor Network
Distributor network expanded to over 400 partners, up from over 250 in Q1 2024, providing increased sales coverage.
Tissue Health Plus Technology Platform Release
The first release of THP's technology platform, including the THP CoPilot app, was announced on May 1st, marking a pivotal milestone in wound care.